Biotemed is a national high-tech enterprise specializing in R&D and production of marine biomaterials. With functional marine polysaccharide chitosan as its core research focus, the company concentrates on absorbable surgical hemostatic materials, wound hemostatic materials, tissue repair materials, and tissue engineering scaffold materials. To date, Biotemed has developed a comprehensive medical care system with 14 sub-brands across four major channels: clinical & hospital channel, military emergency rescue, civilian retail, and pet healthcare. Products comprehensively cover health care areas including high-value consumables, cardiovascular, dental clinics, minimally invasive surgery, hemostasis and repair, wound care, maternal and infant care, medical aesthetics, health food, oral care, intimate care, skincare, eye care, and pet treatment.

Biotemed's scientific research and management team brings together renowned experts in biomaterials, marine biotechnology, clinical medicine, and entrepreneurship from home and abroad, with nearly 30 doctoral and master's students and over 100 expert consultants. The company's research team has undertaken and participated in multiple national science and technology projects including the "863" Program, the National Science and Technology Support Program, and the National Key R&D Program. Technological achievements have been transformed into more than 30 products; the company holds nearly 10 authorized national and internationally accepted invention patents and has received multiple honors including the National Science and Technology Progress Award (Second Class) and the National Marine Science and Technology Award (First Class).

As the National Joint Innovation Research Base for Marine biomaterials Engineering Technology, the Chairman Unit of the China Marine biomaterials Branch, the China Marine biomaterials Expert Workstation, the Qingdao Marine biomaterials Engineering Research Center, and the Qingdao Enterprise Postdoctoral Research Station, Biotemed adheres to its brand culture of "diversity and inclusion, pioneering progress, research for application, and caring for all people." The company actively promotes the integration of industry, academia, and research in marine biomaterials, and has established close cooperative relationships with institutions including Ocean University of China, PLA General Hospital, Peking Union Medical College Hospital, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Renji Hospital, Obstetrics and Gynecology Hospital of Fudan University (Red House Hospital) affiliated with Fudan University, Shandong Provincial Hospital, and the PLA Jinan Military Region General Hospital for product R&D and applied research.

"Integration of production and research, pursuing quality and truth; broad compassion for the public, benefiting the nation and its people" is Biotemed's business philosophy. The company aims to work with all sectors of society to contribute unremittingly to the national marine economy development and make the greatest contribution to human health, guided by its core values of professionalism, rigor, resilience, progress, benevolence, and self-reliance.